Page last updated: 2024-09-05

ahc 52 and 2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide

ahc 52 has been researched along with 2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide in 1 studies

Compound Research Comparison

Studies (ahc 52)	Trials (ahc 52)	Recent Studies (post-2010) (ahc 52)	Studies (2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide)	Trials (2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide)	Recent Studies (post-2010) (2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide)
7	0	0	158	2	52

Protein Interaction Comparison

Protein	Taxonomy	ahc 52 (IC50)	2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide (IC50)
Adenosine receptor A3	Homo sapiens (human)		0.0017

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbracchio, MP; Jacobson, KA; Jiang, JL; Kim, YC; Sei, Y; Yao, Y	1

Other Studies

1 other study(ies) available for ahc 52 and 2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide

Article	Year
Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists. Biochemical and biophysical research communications, 1997, Mar-17, Volume: 232, Issue:2 Topics: Adenosine; Apoptosis; Dihydropyridines; DNA Fragmentation; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Quinazolines; Triazoles	1997

Article

Year

Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists.

Biochemical and biophysical research communications, 1997, Mar-17, Volume: 232, Issue:2

Topics: Adenosine; Apoptosis; Dihydropyridines; DNA Fragmentation; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Quinazolines; Triazoles

1997